Cliff Asness’s vTv Therapeutics VTVT Stock Holding History

Cliff Asness’s Portfolio VTVT Stock Details VTVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,316	Closed	-$120K	–	2338
2021 Q2	$120K	Buy	1,316 +536	+69%	+$54.3K	﹤0.01%	2180
2021 Q1	$88K	Buy	+780	New	+$76.6K	﹤0.01%	2158

Other funds holding VTVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

WAG

Winthrop Advisory Group Boston, Massachusetts $1.48B AUM 22.62% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return

Cliff Asness's VTVT Position: Q3 2021 in Review

Cliff Asness sold out of vTv Therapeutics (VTVT) in Q3 2021, closing a stake of 1,316 shares — an estimated $120K sold.

Cliff Asness first reported a position in VTVT in Q1 2021 and held it in 2 quarters. The position peaked at $120K in Q2 2021. 31 funds tracked by Wall St. Rank hold VTVT as of Q3 2021.

Cliff Asness reported no remaining vTv Therapeutics position as of Q3 2021 after selling out during the quarter.
Cliff Asness sold 1,316 vTv Therapeutics shares in Q3 2021, an estimated $120K.
Cliff Asness first reported a position in vTv Therapeutics in Q1 2021 and held it in 2 quarters.
Cliff Asness's vTv Therapeutics position peaked at $120K in Q2 2021.
31 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2021.

Based on AQR Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.